AngioDynamics, Inc. (FRA:UG2)
Germany · Delayed Price · Currency is EUR 8.70
+0.40 (4.82%)
At close: Jan 30, 2026
AngioDynamics Income Statement
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '25 Nov 30, 2025 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 |
| 307.31 | 292.5 | 303.91 | 338.75 | 316.22 | 291.01 | |
Revenue Growth (YoY) | 7.26% | -3.76% | -10.28% | 7.13% | 8.66% | 10.17% |
Cost of Revenue | 139.59 | 134.79 | 149.22 | 164.51 | 150.49 | 134.22 |
Gross Profit | 167.72 | 157.71 | 154.7 | 174.25 | 165.73 | 156.79 |
Selling, General & Admin | 150.62 | 145.6 | 144.18 | 144.45 | 134.01 | 117.22 |
Research & Development | 27.29 | 25.85 | 31.32 | 29.69 | 30.48 | 36.39 |
Amortization of Goodwill & Intangibles | 10.48 | 10.32 | 13.05 | 18.79 | 19.46 | 18.14 |
Operating Expenses | 188.38 | 181.77 | 188.54 | 192.93 | 183.95 | 171.75 |
Operating Income | -20.67 | -24.06 | -33.84 | -18.68 | -18.22 | -14.96 |
Interest Expense | -0.11 | - | - | -2.7 | -0.69 | -0.86 |
Interest & Investment Income | 0.14 | 0.98 | 1.61 | - | - | - |
Other Non Operating Income (Expenses) | 4.8 | 4.94 | -0.82 | -0.55 | -0.79 | 0.09 |
EBT Excluding Unusual Items | -15.84 | -18.14 | -33.05 | -21.94 | -19.7 | -15.73 |
Merger & Restructuring Charges | -10.69 | -15.4 | -18.13 | -1.46 | -0.7 | -0 |
Impairment of Goodwill | - | - | -159.48 | -14.55 | - | - |
Gain (Loss) on Sale of Assets | - | - | 54.5 | - | - | -0.39 |
Asset Writedown | - | - | - | - | - | -13.95 |
Legal Settlements | -1.99 | -0.72 | -34.94 | -10 | -7.63 | -6.16 |
Other Unusual Items | 0.8 | 0.22 | -0.55 | -6.5 | -1.93 | 0.19 |
Pretax Income | -27.71 | -34.03 | -191.64 | -54.44 | -29.95 | -36.05 |
Income Tax Expense | -0 | -0.04 | -7.29 | -2 | -3.4 | -4.5 |
Earnings From Continuing Operations | -27.71 | -33.99 | -184.35 | -52.44 | -26.55 | -31.55 |
Net Income | -27.71 | -33.99 | -184.35 | -52.44 | -26.55 | -31.55 |
Net Income to Common | -27.71 | -33.99 | -184.35 | -52.44 | -26.55 | -31.55 |
Shares Outstanding (Basic) | 41 | 41 | 40 | 39 | 39 | 38 |
Shares Outstanding (Diluted) | 41 | 41 | 40 | 39 | 39 | 38 |
Shares Change (YoY) | 1.48% | 1.67% | 1.78% | 1.21% | 1.74% | 1.00% |
EPS (Basic) | -0.67 | -0.83 | -4.59 | -1.33 | -0.68 | -0.82 |
EPS (Diluted) | -0.67 | -0.83 | -4.59 | -1.33 | -0.68 | -0.82 |
Free Cash Flow | -9.33 | -14.59 | -30.68 | -3.73 | -22.9 | 10.38 |
Free Cash Flow Per Share | -0.23 | -0.36 | -0.76 | -0.10 | -0.59 | 0.27 |
Gross Margin | 54.58% | 53.92% | 50.90% | 51.44% | 52.41% | 53.88% |
Operating Margin | -6.73% | -8.23% | -11.14% | -5.51% | -5.76% | -5.14% |
Profit Margin | -9.02% | -11.62% | -60.66% | -15.48% | -8.39% | -10.84% |
Free Cash Flow Margin | -3.04% | -4.99% | -10.09% | -1.10% | -7.24% | 3.57% |
EBITDA | -0.15 | -1.66 | -8.53 | 12.19 | 11.13 | 10.95 |
EBITDA Margin | -0.05% | -0.57% | -2.81% | 3.60% | 3.52% | 3.76% |
D&A For EBITDA | 20.52 | 22.4 | 25.31 | 30.87 | 29.35 | 25.92 |
EBIT | -20.67 | -24.06 | -33.84 | -18.68 | -18.22 | -14.96 |
EBIT Margin | -6.73% | -8.23% | -11.14% | -5.51% | -5.76% | -5.14% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.